Literature DB >> 18632864

Leader of the capsid protein in feline calicivirus promotes replication of Norwalk virus in cell culture.

Kyeong-Ok Chang1, David W George, John B Patton, Kim Y Green, Stanislav V Sosnovtsev.   

Abstract

The inability to grow human noroviruses in cell culture has greatly impeded the studies of their pathogenesis and immunity. Vesiviruses, in the family Caliciviridae, grow efficiently in cell culture and encode a unique protein in the subgenomic region designated as leader of the capsid protein (LC). We hypothesized that LC might be associated with the efficient replication of vesiviruses in cell culture and promote the replication of human norovirus in cells. To test this hypothesis, a recombinant plasmid was engineered in which the LC region of feline calicivirus (FCV) was placed under the control of the cytomegalovirus promoter (pCI-LC) so that the LC protein could be provided in trans to replicating calicivirus genomes bearing a reporter gene. We constructed pNV-GFP, a recombinant plasmid containing a full-length NV genome with a green fluorescent protein (GFP) in the place of VP1. The transfection of pNV-GFP in MVA-T7-infected cells produced few GFP-positive cells detected by fluorescence microscopy and flow cytometry analysis. When pNV-GFP was cotransfected with pCI-LC in MVA-T7-infected cells, we observed an increase in the number of GFP-positive cells (ca. 3% of the whole-cell population). Using this cotransfection method with mutagenesis study, we identified potential cis-acting elements at the start of subgenomic RNA and the 3' end of NV genome for the virus replication. We conclude that LC may be a viral factor which promotes the replication of NV in cells, which could provide a clue to growing the fastidious human noroviruses in cell culture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632864      PMCID: PMC2546961          DOI: 10.1128/JVI.00301-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  STAT1-dependent innate immunity to a Norwalk-like virus.

Authors:  Stephanie M Karst; Christiane E Wobus; Margarita Lay; John Davidson; Herbert W Virgin
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

2.  Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR.

Authors:  Tsutomu Kageyama; Shigeyuki Kojima; Michiyo Shinohara; Kazue Uchida; Shuetsu Fukushi; Fuminori B Hoshino; Naokazu Takeda; Kazuhiko Katayama
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Laboratory efforts to cultivate noroviruses.

Authors:  Erwin Duizer; Kellogg J Schwab; Frederick H Neill; Robert L Atmar; Marion P G Koopmans; Mary K Estes
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

4.  Virus replication in engineered human cells that do not respond to interferons.

Authors:  D F Young; L Andrejeva; A Livingstone; S Goodbourn; R A Lamb; P L Collins; R M Elliott; R E Randall
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates.

Authors:  Robert J Ossiboff; Alexander Sheh; Justine Shotton; Patricia A Pesavento; John S L Parker
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

6.  Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  Cell-culture propagation of porcine enteric calicivirus mediated by intestinal contents is dependent on the cyclic AMP signaling pathway.

Authors:  Kyeong-Ok Chang; Yunjeong Kim; Kim Y Green; Linda J Saif
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

8.  Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.

Authors:  N Krieger; V Lohmann; R Bartenschlager
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.

Authors:  Keril J Blight; Jane A McKeating; Joseph Marcotrigiano; Charles M Rice
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  In vitro cell culture infectivity assay for human noroviruses.

Authors:  Timothy M Straub; Kerstin Höner zu Bentrup; Patricia Orosz-Coghlan; Alice Dohnalkova; Brooke K Mayer; Rachel A Bartholomew; Catherine O Valdez; Cynthia J Bruckner-Lea; Charles P Gerba; Morteza Abbaszadegan; Cheryl A Nickerson
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  6 in total

1.  Visualization of feline calicivirus replication in real-time with recombinant viruses engineered to express fluorescent reporter proteins.

Authors:  Eugenio J Abente; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  Virology       Date:  2010-02-04       Impact factor: 3.616

2.  Role of cholesterol pathways in norovirus replication.

Authors:  Kyeong-Ok Chang
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Functional analysis of RNA structures present at the 3' extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence.

Authors:  Dalan Bailey; Ioannis Karakasiliotis; Surender Vashist; Liliane Man Wah Chung; Jivan Rees; Jivan Reese; Nora McFadden; Alicia Benson; Felix Yarovinsky; Peter Simmonds; Ian Goodfellow
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

4.  The feline calicivirus leader of the capsid protein is associated with cytopathic effect.

Authors:  Eugenio J Abente; Stanislav V Sosnovtsev; Carlos Sandoval-Jaime; Gabriel I Parra; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 5.  Functions of the 5' and 3' ends of calicivirus genomes.

Authors:  Bader Alhatlani; Surender Vashist; Ian Goodfellow
Journal:  Virus Res       Date:  2015-02-09       Impact factor: 3.303

6.  Fexaramine as an entry blocker for feline caliciviruses.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  Antiviral Res       Date:  2018-02-15       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.